• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The prevention of congestive heart failure: left ventricular dilation and its management.

作者信息

Firth B G, Dunnmon P M

机构信息

Cardiology Division, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

Am J Med Sci. 1990 Apr;299(4):276-90. doi: 10.1097/00000441-199004000-00010.

DOI:10.1097/00000441-199004000-00010
PMID:2157339
Abstract

Left ventricular dilation and remodelling occur in 35-40% of anterior transmural myocardial infarcts and these events are important antecedents to the development of late congestive heart failure. This process commences within the first 24 hours following myocardial infarction and may be steadily progressive over months to years. Both the infarcted and the uninfarcted regions of myocardium are equally involved in the process. Thinning of the left ventricular wall occurs mainly as a result of cell slippage. In addition, compensatory hypertrophy occurs in the uninfarcted segment of the myocardium. While this hypertrophy may initially be physiological, it ultimately appears to become a pathological process and thereby contributes to pump dysfunction. At the present time there are encouraging data to suggest that nitroglycerin, administered in the setting of the acute infarction, or the angiotensin converting enzyme inhibitor captopril, may ameliorate this process. Whether a patent infarct related artery further limits dilation is uncertain and is currently under investigation.

摘要

相似文献

1
The prevention of congestive heart failure: left ventricular dilation and its management.
Am J Med Sci. 1990 Apr;299(4):276-90. doi: 10.1097/00000441-199004000-00010.
2
Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic interventions.
Cardiovasc Drugs Ther. 1990 Oct;4(5):1363-74. doi: 10.1007/BF02018264.
3
Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition.实验性心肌梗死中进行性心室扩张及其通过血管紧张素转换酶抑制作用的减轻。
Am J Cardiol. 1991 Nov 18;68(14):17D-25D. doi: 10.1016/0002-9149(91)90257-l.
4
Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement.急性透壁性心肌梗死梗死节段的早期扩张:梗死扩展在急性左心室扩大中的作用
J Am Coll Cardiol. 1984 Aug;4(2):201-8. doi: 10.1016/s0735-1097(84)80203-x.
5
Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
Eur Heart J. 1993 Jul;14 Suppl C:14-7. doi: 10.1093/eurheartj/14.suppl_c.14.
6
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.心肌梗死后的心室重构。实验观察与临床意义。
Circulation. 1990 Apr;81(4):1161-72. doi: 10.1161/01.cir.81.4.1161.
7
The renin-angiotensin system in left ventricular remodeling.
Am J Cardiol. 1996 May 30;77(13):8C-16C. doi: 10.1016/s0002-9149(96)00183-x.
8
Ventricular enlargement following infarction is a modifiable process.梗死后心室扩大是一个可改变的过程。
Am J Cardiol. 1991 Nov 18;68(14):127D-131D. doi: 10.1016/0002-9149(91)90270-u.
9
Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role?
J Cardiovasc Pharmacol. 1992;20 Suppl 1:S41-7.
10
Cellular basis of ventricular remodeling after myocardial infarction.心肌梗死后心室重构的细胞基础。
Am J Cardiol. 1991 Nov 18;68(14):7D-16D. doi: 10.1016/0002-9149(91)90256-k.

引用本文的文献

1
Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta-analysis.左西孟旦对左心室收缩功能障碍患者心室重构的影响:一项荟萃分析。
ESC Heart Fail. 2024 Jun;11(3):1352-1376. doi: 10.1002/ehf2.14714. Epub 2024 Feb 28.
2
Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.卡托普利。关于其在心肌梗死后及缺血性心脏病中的药理学和治疗效果的综述。
Drugs Aging. 1995 Sep;7(3):226-53. doi: 10.2165/00002512-199507030-00007.